{
  "title": "Central Nervous System Therapeutics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "central-nervous-system-therapeutics-market",
  "industry": "Pharmaceuticals & Therapeutics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/central-nervous-system-therapeutics-market",
  "scraped_at": "2026-09-17T17:45:18+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 143.32,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 197.35,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 6.62,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "What is the current valuation and growth outlook for the central nervous system therapeutics space?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The segment is valued at USD 143.32 billion in 2026 and is projected to climb to USD 197.35 billion by 2031, reflecting a 6.62% CAGR."
      }
    },
    {
      "@type": "Question",
      "name": "Which therapeutic class is expanding the fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Disease-modifying therapies are forecast to grow at a 6.83% CAGR through 2031 as payers and clinicians prioritize treatments that slow or alter disease progression."
      }
    },
    {
      "@type": "Question",
      "name": "Why is Alzheimer's disease drawing heightened investment?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Regulatory acceptance of amyloid-targeting drugs such as lecanemab and donanemab has created a new treatment category, positioning Alzheimer’s as the fastest-growing indication at a 7.05% CAGR."
      }
    },
    {
      "@type": "Question",
      "name": "How do biologics compare with small molecules in future growth?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Although small molecules still hold over 70% revenue share, biologics including gene and antibody therapies—are advancing at a 7.52% CAGR thanks to improvements in brain delivery technologies."
      }
    },
    {
      "@type": "Question",
      "name": "Which region is expected to contribute most to incremental revenues?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is projected to record a 7.78% CAGR to 2031, driven by China's regulatory reforms, Japan’s fast-track pathways, and expanding healthcare access across emerging economies."
      }
    },
    {
      "@type": "Question",
      "name": "What competitive trend is reshaping deal activity?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Large pharmaceutical companies are acquiring or partnering with biotech firms that possess differentiated mechanisms, exemplified by multi-billion-dollar transactions for schizophrenia, gene, and psychedelic programs."
      }
    }
  ],
  "images": [
    "images/central-nervous-system-therapeutics-market-size.png",
    "images/central-nervous-system-therapeutics-market-major-players.png",
    "images/central-nervous-system-therapeutics-market-share-by-therpeutic-class.png",
    "images/central-nervous-system-therapeutics-market-share-by-drug-type.png",
    "images/central-nervous-system-therapeutics-market-growth-rate-by-region.png",
    "images/central-nervous-system-therapeutics-market-competitive-landscape-market-concentration.png",
    "images/market-snapshot.png",
    "images/pdf3.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/central-nervous-system-therapeutics-market-size.png"
  ],
  "sections_count": 14
}